Trials / Unknown
UnknownNCT04223076
Clinical Effect of Chlorhexidine Mouthwash After Periodontal Surgery
Clinical Performance of Two 0.2% Chlorhexidine Mouth Rinses After Periodontal Surgery. A Blinded, Intra-individual Cross-over Clinical Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 31 (estimated)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Chlorhexidine is the gold standard of dental plaque prevention. Recent research have demonstrated that 0.2% Chlorhexidine solutions are more effective than 0.12% and 0.06% Chlorhexidine solutions. Several 0.2% solutions are available on the market. This study aimed to compare effectiveness of two commercially available 0.2% chlorhexidine mouthwashes. Patients, that after initial periodontal therapy, had a need for two periodontal surgeries, will be invited to join. After one surgical session, the patient will receive one 0.2% chlorhexidine solution, and after the next surgical session the patient will receive the other 0.2% chlorhexidine solution. Plaque and gingivitis will be recorded, as well as side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorhexidine 0.2%, Corsodyl | Comparison of Corsodyl and Curasept |
| DRUG | Chlorhexidine 0.2%, Curasept | Chlorhexidine 0.2% mouthwash with an Anti Discoloring System (ADS) |
Timeline
- Start date
- 2019-03-20
- Primary completion
- 2019-12-20
- Completion
- 2020-12-30
- First posted
- 2020-01-10
- Last updated
- 2020-01-13
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04223076. Inclusion in this directory is not an endorsement.